Trichoepithelioma
To view the entire topic, please log in or purchase a subscription.
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
- A benign cutaneous neoplasm of the hair follicle
- Trichoepithelioma (TE) commonly presents as a solitary skin-colored papule or nodule on the face.
- Multiple lesions are seen in several autosomal dominant disorders including Brooke-Spiegler syndrome, Brooke disease, Rombo syndrome, and Bazex-Dupré-Christol syndrome.
- There are three variants of TE: (i) solitary, (ii) multiple familial TE (MFT), and (iii) desmoplastic TE (DTE).
- Can be mistaken for basal cell carcinoma (BCC) or Gorlin syndrome (multiple BCCs)
Epidemiology
- Predominantly occurs in young adults
- Multiple lesions may occur in children and adolescents with associated autosomal dominant disorders.
- A distinct variation known as giant solitary TE may occur in the elderly.
Incidence
Incidence unknown
Prevalence
- Rare (affects <1 person per 2,000)
- Female > male (2:1)
Etiology and Pathophysiology
- The short arm of chromosome 9 is known to encode proteins that can arrest the cell cycle by binding CDK4/6. Tumorigenesis is believed to occur when deletion or rearrangements near 9p21 inactivates these proteins, causing decreased CDK4 kinase binding and increased phosphorylation of the retinoblastoma tumor suppressor protein.
- Familial cases of TE are due a mutation of CYLD gene, a tumor suppressor gene that plays a role in deubiquitinating proteins. These proteins negatively regulate the nuclear factor-κB (NF-κB) signaling pathway. Loss of CYLD heterozygosity promotes tumor growth through continuous NF-κB activation, unregulated cell division, and resistance to apoptosis.
Commonly Associated Conditions
- Brooke-Spiegler syndrome
- Familial cylindromatosis (FC)
- BCC
- Gorlin syndrome
- Rombo syndrome (atrophoderma, milia, hypotrichosis, TE, BCC, peripheral vasodilatation)
Genetics
TE displays genetic heterogeneity; the two most prevalent mutations have been mapped to the following:
- 9p21 → Autosomal dominant mutation in a tumor suppressor gene gives rise to the familial form of TE (MFT).
- 16q12 to 16q13 (CYLD gene) → results in a spectrum of disease phenotypes including the following:
- MFT
- FC
- Brooke-Spiegler syndrome, which demonstrates features of MFT and FC
Risk Factors
- Female gender (due to increased disease penetrance)
- Family history
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
- A benign cutaneous neoplasm of the hair follicle
- Trichoepithelioma (TE) commonly presents as a solitary skin-colored papule or nodule on the face.
- Multiple lesions are seen in several autosomal dominant disorders including Brooke-Spiegler syndrome, Brooke disease, Rombo syndrome, and Bazex-Dupré-Christol syndrome.
- There are three variants of TE: (i) solitary, (ii) multiple familial TE (MFT), and (iii) desmoplastic TE (DTE).
- Can be mistaken for basal cell carcinoma (BCC) or Gorlin syndrome (multiple BCCs)
Epidemiology
- Predominantly occurs in young adults
- Multiple lesions may occur in children and adolescents with associated autosomal dominant disorders.
- A distinct variation known as giant solitary TE may occur in the elderly.
Incidence
Incidence unknown
Prevalence
- Rare (affects <1 person per 2,000)
- Female > male (2:1)
Etiology and Pathophysiology
- The short arm of chromosome 9 is known to encode proteins that can arrest the cell cycle by binding CDK4/6. Tumorigenesis is believed to occur when deletion or rearrangements near 9p21 inactivates these proteins, causing decreased CDK4 kinase binding and increased phosphorylation of the retinoblastoma tumor suppressor protein.
- Familial cases of TE are due a mutation of CYLD gene, a tumor suppressor gene that plays a role in deubiquitinating proteins. These proteins negatively regulate the nuclear factor-κB (NF-κB) signaling pathway. Loss of CYLD heterozygosity promotes tumor growth through continuous NF-κB activation, unregulated cell division, and resistance to apoptosis.
Commonly Associated Conditions
- Brooke-Spiegler syndrome
- Familial cylindromatosis (FC)
- BCC
- Gorlin syndrome
- Rombo syndrome (atrophoderma, milia, hypotrichosis, TE, BCC, peripheral vasodilatation)
Genetics
TE displays genetic heterogeneity; the two most prevalent mutations have been mapped to the following:
- 9p21 → Autosomal dominant mutation in a tumor suppressor gene gives rise to the familial form of TE (MFT).
- 16q12 to 16q13 (CYLD gene) → results in a spectrum of disease phenotypes including the following:
- MFT
- FC
- Brooke-Spiegler syndrome, which demonstrates features of MFT and FC
Risk Factors
- Female gender (due to increased disease penetrance)
- Family history
There's more to see -- the rest of this topic is available only to subscribers.